These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34178211)

  • 21. The incidence of hypogonadotropic hypogonadism in type 2 diabetic men in Polish population.
    Rabijewski M; Papierska L; Zgliczyński W; Piątkiewicz P
    Biomed Res Int; 2013; 2013():767496. PubMed ID: 24222915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low Serum Testosterone Levels in Male Patients with Type 2 Diabetes Mellitus as a Risk Factor for Coronary Artery Disease.
    Saluja M; Galav V; Pillai D; Chittora S
    J Assoc Physicians India; 2021 Sep; 69(9):11-12. PubMed ID: 34585886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic.
    Corona G; Mannucci E; Petrone L; Ricca V; Balercia G; Mansani R; Chiarini V; Giommi R; Forti G; Maggi M
    Int J Impot Res; 2006; 18(2):190-7. PubMed ID: 16136189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive Indices of MASLD Are Associated With Hypogonadism in Male Patients With Type 2 Diabetes Mellitus.
    Caretta N; Scafa R; Graziani A; Crepaldi MC; Vedovato M; Avogaro A; Ferlin A
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e522-e530. PubMed ID: 37795977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum testosterone in Nigerian men with type 2 diabetes mellitus and its relationship with insulin sensitivity and glycemic control.
    Sepu N; Adeleye JO; Kuti MO
    J Natl Med Assoc; 2021 Jun; 113(3):285-293. PubMed ID: 33353658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes.
    Stanworth RD; Kapoor D; Channer KS; Jones TH
    Diabetes Care; 2009 Apr; 32(4):541-6. PubMed ID: 19114614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen Deficiency in Aging Male Questionnaire for the Clinical Detection of Testosterone Deficiency in a Population of Black Sub-Saharan African Men with Type 2 Diabetes Mellitus: Is it a Reliable Tool?
    Ugwu ET; Ikem RT
    Curr Diabetes Rev; 2018; 14(3):280-285. PubMed ID: 28031016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of and risk factors for androgen deficiency in aging Taiwanese men.
    Liu CC; Wu WJ; Lee YC; Wang CJ; Ke HL; Li WM; Hsiao HL; Yeh HC; Li CC; Chou YH; Huang CH; Huang SP
    J Sex Med; 2009 Apr; 6(4):936-946. PubMed ID: 19210712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism.
    George JT; Veldhuis JD; Tena-Sempere M; Millar RP; Anderson RA
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):100-4. PubMed ID: 23153270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone deficiency syndrome among males with type 2 diabetes mellitus in East Malaysia.
    Ahmad S; Jerampang P; Tohid H; Ali MF; Jamil TR; Kong CHC
    Nagoya J Med Sci; 2020 Nov; 82(4):613-621. PubMed ID: 33311792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort.
    O'Reilly MW; Glisic M; Kumarendran B; Subramanian A; Manolopoulos KN; Tahrani AA; Keerthy D; Muka T; Toulis KA; Hanif W; Thomas GN; Franco OH; Arlt W; Nirantharakumar K
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):145-154. PubMed ID: 30256433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors of hypogonadism in men with chronic renal failure.
    Oueslati I; Ounissi M; Talbi E; Azaiez S; Bacha MM; Ben Abdallah T
    Tunis Med; 2020 Feb; 98(2):138-143. PubMed ID: 32395803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiometabolic indices predict hypogonadism in male patients with type 2 diabetes.
    Caretta N; Facondo P; Mereu S; Delbarba A; Crepaldi MC; Vedovato M; Avogaro A; Ferlin A
    J Endocrinol Invest; 2023 Mar; 46(3):599-608. PubMed ID: 36282472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life.
    Biswas M; Hampton D; Newcombe RG; Rees DA
    Clin Endocrinol (Oxf); 2012 May; 76(5):665-73. PubMed ID: 21854402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for hypogonadism in diabetes 2008/9: results from the Cheshire Primary Care cohort.
    Anderson SG; Heald A; Younger N; Bujawansa S; Narayanan RP; McCulloch A; Jones H
    Prim Care Diabetes; 2012 Jul; 6(2):143-8. PubMed ID: 21982717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.
    Haider KS; Haider A; Saad F; Doros G; Hanefeld M; Dhindsa S; Dandona P; Traish A
    Diabetes Obes Metab; 2020 Nov; 22(11):2055-2068. PubMed ID: 32558149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship Between Gonadal Function and Cardiometabolic Risk in Young Men With Chronic Spinal Cord Injury.
    Sullivan SD; Nash MS; Tefara E; Tinsley E; Groah S
    PM R; 2018 Apr; 10(4):373-381. PubMed ID: 28827206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for late-onset hypogonadism.
    Yang QT; Wu KS; Li ZJ; Li WC; Lu L; Wu HQ; Zhuang YY; Sui XX
    Andrologia; 2018 Aug; 50(6):e13016. PubMed ID: 29665142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of Hypogonadism in Type 2 Diabetes Mellitus Patients with and without Coronary Artery Disease.
    Raza MT; Sharif S; Khan ZA; Naz S; Mushtaq S; Umer A
    Cureus; 2019 Dec; 11(12):e6500. PubMed ID: 32025421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.